Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
| Title
|
Date published
|
|
|
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series
|
2024-02-16
|
|
|
|
Colorectal Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on Biomarker Assessment and Related Treatment Decision-Making for Patients with Colorectal Cancer
|
2024-02-15
|
|
|
|
Urothelial Bladder Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Urothelial Bladder Cancer
|
2024-02-09
|
|
|
|
Gastroesophageal Cancers | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Gastroesophageal Cancers
|
2024-02-07
|
|
|
|
Hormone Receptor-Positive Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
|
2024-02-01
|
|
|
|
Hormone Receptor-Positive Breast Cancer | Erica Mayer, MD, MPH, FASCO
|
2024-02-01
|
|
|
|
Hormone Receptor-Positive Breast Cancer | Stephanie L Graff, MD, FACP
|
2024-02-01
|
|
|
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
|
2024-01-24
|
|
|
|
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
|
2024-01-17
|
|
|
|
Multiple Myeloma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Multiple Myeloma
|
2024-01-10
|
|
|
|
Diffuse Large B-Cell Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Diffuse Large B-Cell Lymphoma
|
2024-01-08
|
|
|
|
HER2-Low Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Low Breast Cancer
|
2024-01-04
|
|
|
|
Chronic Lymphocytic Leukemia | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Chronic Lymphocytic Leukemia
|
2024-01-03
|
|
|
|
HER2-Negative Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Localized HER2-Negative Breast Cancer
|
2023-12-28
|
|
|
|
Follicular, Mantle Cell and Hodgkin Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Follicular, Mantle Cell and Hodgkin Lymphoma
|
2023-12-27
|
|
|
|
ER-Positive Metastatic Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of ER-Positive Metastatic Breast Cancer
|
2023-12-21
|
|
|
|
Gynecologic Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
|
2023-12-20
|
|
|
|
Biliary Tract Cancer | Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
|
2023-12-14
|
|
|
|
Biliary Tract Cancer | Milind Javle, MD
|
2023-12-14
|
|
|
|
Biliary Tract Cancer | Lipika Goyal, MD, MPhil
|
2023-12-14
|
|
|
